What are different phases of clinical trials for arthritis?
Clinical trials are done in phases:
Phase I: A small number of people are given the new arthritis treatment. The researchers decide the best way to give it and how much of it can be given safely.
Phase II: Determines how people responded to treatment and usually the best dosage.
Phase III: The drug or treatment is given to large groups of people to confirm that it works, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used
Phase IV: The new therapy is released to the market. Data is collected on how the drug affects different populations and if there are side effects with long-term use.
From: A Guide to Clinical Trials for Arthritis Patients WebMD Medical Reference
More Answers On Arthritis
- What are advantages of joining a clinical trials for arthritis?
- What are the possible risks of taking part in a clinical trial for arthritis treatment?
- What is informed consent in relation to clinical trials for arthritis?
- What questions should you ask when you take a part in a clinical trial for arthritis?
THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.
This tool does not provide medical advice. See additional information.